Results 91 to 100 of about 579,519 (167)

sj-pdf-1-tam-10.1177_17588359241229425 – Supplemental material for Development and validation of a nomogram for Siewert II esophagogastric junction adenocarcinoma: a retrospective analysis

open access: yes
Supplemental material, sj-pdf-1-tam-10.1177_17588359241229425 for Development and validation of a nomogram for Siewert II esophagogastric junction adenocarcinoma: a retrospective analysis by Tao Jin, Ze-Dong Li, Ze-Hua Chen, Feng-Jun He, Zheng-Wen Chen ...
Ze-Dong Li (8606583)   +7 more
core   +1 more source

sj-docx-1-aan-10.1177_02184923241238486 - Supplemental material for Siewert II esophagogastric junction adenocarcinoma: Still searching for the right treatment transabdominal or transthoracic surgical approaches?

open access: yes
Supplemental material, sj-docx-1-aan-10.1177_02184923241238486 for Siewert II esophagogastric junction adenocarcinoma: Still searching for the right treatment transabdominal or transthoracic surgical approaches?
Sofien Sayari (18273068)   +8 more
core   +1 more source

Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction

open access: yes, 2010
Background \ud Adenocarcinoma of the esophagogastric junction (AEG) as described by Siewert et al. is classified as one entity in the latest (7th Edition) American Joint Cancer Committee/International Union Against Cancer (AJCC/UICC) manual, compared ...
Ravi, Naraymasamy   +15 more
core   +1 more source

Clinical effect of endoscopic submucosal dissection in the treatment of Siewert type Ⅱ early adenocarcinoma and precancerous lesions of esophagogastric junction

open access: yesZhongguo linchuang yanjiu
Objective To evaluate the efficacy and safety of endoscopic submucosal dissection (ESD) in the treatment of Siewert type Ⅱ early adenocarcinoma of the esophagogastric junction (AEG) and esophagogastric junction (EGJ) precancerous lesions.
GUO Huiwen, HE Qibin, LIU Yang, TIE Guangxuan, CHEN Yijia
doaj   +1 more source

Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction

open access: yes, 2007
Copyright © 2007 Chinese Medical Journal, All Rights Reserved.BackgroundEsophageal adenocarcinoma is becoming an increasingly important problem. It has been the most rapidly increasing malignancy in western countries in the last decades, and its ...
Watson, D.   +8 more
core   +1 more source

Selection of two intrathoracic anastomosis methods for transabdominal radical surgery for Siewert type II adenocarcinoma of the esophagogastric junction

open access: yesVideosurgery and Other Miniinvasive Techniques, 2022
Yun Huang   +7 more
doaj   +1 more source

Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)

open access: yesBMC Cancer
Background For resectable adenocarcinoma of the esophagogastric junction (AEG), current treatment exploration primarily focuses on perioperative chemotherapy regimens combined with PD-1/PD-L1 inhibitors, but the long-term survival benefits of still ...
Yingyi Li   +5 more
doaj   +1 more source

Molecular profiling of adenocarcinoma of esophagogastric junction.

open access: yes, 2017
65 Background: Biologic understanding of adenocarcinoma of esophagogastric junction (AEJ) and similarity to gastric or esophageal adenocarcinoma has been long standing controversial issue, especially according to Siewert classification.
Jong-Il Kim   +12 more
core   +1 more source

Involvement of long non-coding RNA NORAD in short-term poor prognosis of neoadjuvant chemotherapy in adenocarcinoma of esophagogastric junction

open access: yesAnnals of Medicine
Background Adenocarcinoma of the esophagogastric junction (AEG) is a common upper gastrointestinal malignancy.Aim This study investigates the impact of long non-coding RNA NORAD on the short-term efficacy of oxaliplatin-based neoadjuvant chemotherapy in ...
Shoumiao Li   +4 more
doaj   +1 more source

Outcomes of Microscopic Residual Tumor after Curative-Intent Surgery in Adenocarcinoma of Esophagogastric Junction

open access: yesSiriraj Medical Journal
Objective: Radical surgery is the mainstay treatment for adenocarcinoma of the esophagogastric junction. The presence of microscopic residual tumor tissue after curative-intent surgery is associated with recurrence.
Chawisa Nampoolsuksan   +12 more
doaj  

Home - About - Disclaimer - Privacy